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Simian immunodeficiency virus (SIVmac251)membrane lipid mixing with
human CD4 + and CD4- cell lines in vitro does not necessarily result in
internalization of the viral core proteins and productive infection
L e o n i d a s Stamatatosl-~ and Nejat Diizgiine§ 1,2.
1Department of Microbiology, University of the Pacific School of Dentistry, 2155 Webster Street, San Francisco,
California 94115-2399 and 2Department of Pharmaceutical Chemistry, University of California, San Francisco,
California 94143-0128, U.S.A.

The cell binding site of simian immunodeficiency virus
(SIV) is believed to be the CD4 molecule. Several CD4 +
cell lines are, however, resistant to infection by SIVmae251
in vitro and additional cell membrane molecules have
been implicated in SIV.... 251 entry. We investigated the
binding, envelope fusion and entry of the viral core
proteins (p27) of SIVm~c251 into two human CD4 + cell
lines (H9 and Sup-T1) which are infectible, and one
CD4 + (A3.01) and two CD4- cell lines (K562 and Raji)
that are resistant to infection. The fusion of the viral and
cellular membranes was monitored by a fluorescence
assay for lipid mixing. Cell entry of the viral core was
evaluated following virus-cell incubation and cell surface trypsinization. We found that SIV.... 251 can bind to
and fuse (membrane lipid mixing) in a temperature-

dependent but pH-independent fashion with CD4 + and
CD4- human-derived cell lines. In contrast, lipid mixing
with CD4 expressing EL-4 mouse T cells or Mv-l-lu
mink lung fibroblasts was absent or limited, suggesting
that certain components of human cell membranes in
addition to CD4 are involved in SIV .... envelope-cell
fusion. Lipid mixing with the human cells was inhibited
partially by soluble CD4. Anti-CD4 antibodies inhibited
the lipid inter-mixing with Hg, but not with Raji cells,
whereas neutralizing anti-SIVm~o sera inhibited fusion
with both CD4 + and CD4 cells. Out of the five human
cell lines tested, efficient entry of p27 and productive
infection took place only with H9 and Sup-T1 cells. In
these two cases, the amounts of p27 internalized during
virus-cell fusion correlated with the extent of infection.

Introduction

significant evidence from & vitro and in vivo studies that
SIV and HIV can also infect CD4- lymphocytes as well
as cells that are not part of the immune system
(Benveniste et al., 1988; Harouse et al., 1991a; Kunsch
& Wigdahl, 1991 ; Lackner et al., 1991 ; Langhoff et at.,
1991 ; Moyer & Gendelman, 1991 ; Tateno et al., 1989).
Important differences between SIV and HIV type 1
(HIV-1) have been noted regarding the mechanism(s) by
which these viruses infect CD4 + cell lines. It was shown
previously that several CD4 + lymphoid cell lines are
resistant to SIV .....251 and SIVMne (Macaca nemestrina)
infection, although they are infectible with HIV-1
(HTLV-IIIB strain) (Agy et at., 1991; Hoxie et al., 1988;
Koenig et al., 1989).
HIV and SIV infect their target cells following viral
envelope fusion with the cell plasma membrane (McClure
et al., 1988; Stein et al., 1987). It is generally assumed
that HIV and SIV will fuse only with the plasma
membrane of cells that they can infect. The resistance to
infection of certain CD4 + cell lines could be due to
inefficient virus-cell binding and/or fusion of the viral

Simian immunodeficiency viruses (SIVs) are retroviruses
that infect non-human primates (Allan et al., 1990;
Benveniste et aL, 1986; Daniel et at., 1985; Fults et at.,
1986), and share common structural and biological
characteristics with human immunodeficiency viruses
(HIVs) (Chakrabarti et al., 1987; Dietrich et al., 1989;
Franchini et al., 1987; Kanki et al., 1985; Lowenstine et
al., 1986; Murphey-Corb et al., 1986). The primary cell
targets of SIV and HIV in their respective hosts are
lymphocytes and monocytes that express the CD4
antigen on their surface (Dalgleish et al., 1984; Kannagi
et al., 1985; Klatzmann et al., 1984; McDougal et al.,
1985). Several in vitro studies have indicated, however,
that not all CD4 + cell lines can be infected by these
viruses (Clapham et al., 1991). In addition, there is
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envelope with these cell membranes. It is also possible
that, although virus-cell fusion and viral entry occur
both with the 'non-infectible' and 'infectible' cells, the
level of virus replication is controlled by cytoplasmic
factors.
In order to examine to what extent SIV.... 251-cell
interactions proceed in the case of non-infectible cells, we
investigated the binding and fusion of this virus with the
cell plasma membranes of three CD4 + human cell lines
(H9, Sup-T1 and A3.01), which have been shown
previously to have a widely different capacity to support
SIV~o infection (Hoxie et al., 1988; Koenig et al., 1989),
two CD4- human cells (Raji and K562), one CD4 + mink
cell line (Mv-l-lu) and one CD4 + mouse T cell line (EL4). To follow the kinetics of the SIV .....251-cell fusion,
we employed the octadecylrhodamine (R~8) fluorescence
assay for the mixing of lipids between the viral envelope
and the cell plasma membrane (Hoekstra et al., 1984;
Dtizgiine~ & Bentz, 1988). This method has been used
extensively to examine the interaction of several enveloped viruses with cell membranes (Dfizgtine~ et al.,
1992; Gilbert et al., 1990; Herrmann et al., 1990;
Hoekstra & Klappe, 1986; Lima et al., 1991; Sinangil et
al., 1988; Srinivasakumar et al., 1991; Volsky, 1990).
To examine whether lipid mixing is always accompanied by the delivery of the viral nucleocapsid, we
monitored the entry of SIV .....251 core proteins into the
cell cytoplasm in the cases where extensive membrane
fusion took place. We also examined whether SIVm~e251-cell fusion and nucleocapsid entry leads to productive
infection, by determining the production of new virions
in the culture medium up to 28 days post-fusion (i.e.
post-infection).
We demonstrate that the envelope of SIV .....251 could
bind to and mix lipids extensively with the plasma
membrane of all the human-derived CD4 + and CD4 cell
lines used. Minimal membrane fusion with the nonhuman CD4 + cell lines was monitored. Efficient entry of
p27 and productive infection was only detected in the
case of H9 and Sup-T1 cells. In these two cases the level
of infection correlated with the amount of viral core
protein internalized during virus-cell fusion. Minimal
membrane fusion with all the non-human cell lines was
monitored. A preliminary account of our observations
has been presented (Stamatatos & Dfizgtine~, 1992).

Methods
Materials. Recombinant soluble CD4 (sCD4) (corresponding to the
ectodomain) was a gift from Genentech. R~8 was purchased from
Molecular Probes and the non-ionic detergent C12E9 from Calbiochem.
Goat anti-human K light chain was from Tago, and anti-Leu3a
antibodies were from Becton-Dickinson. Anti-SIVm~c251 neutralizing
sera were kindly provided by Dr J. V. Torres (University of California
at Davis, Calif., U.S.A.).

Cells. A3.01 cells were obtained from T. Folks (Centers for Disease
Control, Atlanta, Ga., U.S.A.). Raji cells, a human Burkitt's lymphoma
cell line, were obtained from Microbiological Associates through Dr P.
Madden (NIH). H9 cells were obtained from Dr R. C. Gallo and SupT1 cells from Dr J. Hoxie, through the NIAID AIDS Research and
Reference Reagent Program. The K562 cell line was obtained from the
American Type Culture Collection. The percentage of CD4 + cells
present in each cell line was determined by flow cytometry every 4 to 6
weeks. The mouse T cell line stably expressing human CD4 (EL-4) was
provided by Dr A. Koito (The Institute of Physical and Chemical
Research, Tsukuba-city 305, Japan). All the above cell lines were
cultured at 37 °C, with 5 % CO~ in RPMI-1640 medium supplemented
with 10 % (v/v) heat-inactivated fetal bovine serum (FBS). The CD4 +
mink lung cell line (Mv-l-lu) was obtained from Dr P. Clapham
(Chester Beatty Laboratories, Institute of Cancer Research, London,
U.K.) via Dr J. Levy (University of California at San Francisco, Calif.,
U.S.A.). They were grown in MEM supplemented with 5 % FBS.
Virus production and purification. All experiments involving virus
were conducted in a BSL-3 facility as recommended by the Centers for
Disease Control (1988). Sucrose density gradient-purified SIVm~c251
was obtained from Advanced Biotechnologies. The virus was grown in
HUT-78 cells. Cell supernatant was harvested and clarified by
centrifugation. The virus was centrifuged at 19000 r.p.m, in a Beckman
type 19 rotor for 90 rain at 5 °C. The pelleted virus was resuspended
and then banded over a 20/40% (w/w) sucrose gradient at
35000 r.p.m, for 2 h in a Beckman type 35 rotor. The purified virus was
recovered from the 20/40 % sucrose interface. Thereafter, the virus was
resuspended in 10 mM-Tris-HC1, 150 mM-NaC1 pH 7-5. The purified
viral preparation contained all the major viral proteins (p14, p26, p32,
gp40, p55, p66 and gpl20) as determined by Western immunoblot
assay. The reverse transcriptase activity was 5.50× 108c.p.m./ml
(rA: dT template, percentage rA activity: 99-6 %). The virus was stored
in small samples at - % °C until further use.
Virus labelling. For each experiment 50 or 100 gg total viral protein
was thawed and the viral envelope was labelled with R18 as reported
previously (Konopka et al., 1990; Larsen et al., 1990). Briefly, the virus
was incubated with an ethanolic solution of R18 (final ethanol
concentration of less than 1% v/v) for 60 rain at room temperature.
The final R18 concentration in the viral envelope was less than 3 % of
the total viral lipid. The stock R~s-labelled virus was kept on ice for the
duration of each experiment. The presence of R~8 did not alter the
fusion properties of our viral preparation since similar quantities of p27
were internalized during fusion whether the viral envelope was labelled
with R18 or not (data not shown). The virus remained infectious
following R~s labelling (see Results).
Determination of p27. To quantify the amount of viral core proteins
introduced into the cytoplasm during virus--cell fusion, we determined
the amounts of p27 internalized by using the SIV core antigen capture
assay kit from Coulter Immunology. Cell lysates were added to wells
coated with a murine monoclonal antibody to p27. A second, human
biotinylated antibody was added, which reacted with conjugated
streptavidi~horseradish peroxidase. Colonr developed upon addition
of hydrogen peroxide in the presence of 3,3',5,5'-tetramethylbenzidine.
The intensity of the colour is dependent upon the amount of p27
present. In control wells, lysates from cells that had not been incubated
with virus were added. The same assay was also used to evaluate the
production of new virions in the cell culture medium during productive
cell infection.
Binding of SIVm~c251 to cells. All binding and fusion studies were
performed in RPMI-1640 medium without phenol red, containing
25 mM-HEPES (Medium A). Increasing amounts of R18-1abelled
SIVm~~ were incubated with 2 x 10~ cells in 0-1 ml of Medium A for

Fusion and infectivity of S[Vm. ~251
30 min at 4 °C. The mixture was then diluted 20-fold with the same
medium and centrifuged at 200 g for 10 min at 4 °C. The cell pellet was
washed twice. During the first centrifugation, almost 95 % of the
u n b o u n d virus was removed from the cell pellet (detemained from the
extent of R18 fluorescence recovered in the cell supernatant following
each wash). The R18 fluorescence in the cell pellet and in the combined
supernatants was measured, and the a m o u n t of cell-associated SIVmao
was evaluated. The a m o u n t of b o u n d virus was quantified in parallel by
measuring the a m o u n t of p27 associated with the cells. Both assays
gave similar results.

Virus-cell fusion. All fusion experiments were performed in Medium
A. The Rts fluorescence assay was used to monitor the intermixing of
the viral envelope with the cell plasma m e m b r a n e (Hoekstra et al.,
1984). The fluorescence of R~8 depends on the concentration of the
probe in the membrane. Initially, the probe is introduced into the viral
envelope at a concentration that results in the quenching of its
fluorescence. U p o n virus-cell fusion, the fluorophore is diluted in the
much larger area of the cell plasma membrane, resulting in an increase
of fluorescence. All fluorescence measurements (555 n m excitation,
595 n m emission, with a 590 n m low end cut-off filter) were carried out
with a Perkin-Elmer LS-5B fluorescence spectrophotometer. In order
to minimize the effects of light scattering produced by high cell
concentrations, the front face configuration was used. The cells were
washed twice with PBS, once with M e d i u m A and then kept on ice until
use. Virus and suspension cells, at a ratio of 1 lag viral protein/2 x 10 ~
cells, were pre-incubated at 4 °C for 30 rain and then the temperature
of the mixture was raised to 37 °C. Samples of 100 lal were taken at
various times and diluted 20-fold with M e d i u m A. Their fluorescence
was measured before and after the addition of detergent to a final
concentration of 1% (v/v). Since Rls is diluted maximally in the
presence of detergent, the fluorescence in the presence of detergent is
taken as 100% fusion. In the case of the adherent cells (Mv-l-lu),
following the incubation o f the virus with the cells for various periods
of time, the cell supernatant was removed and the cells were recovered
from the plate following a 1 0 m i n incubation with calcium- and
magnesium-free PBS (containing 5 mM-EDTA). The cells and the
virus-containing supernatant were then re-combined, and the extent of
fusion was determined as described below.
The extent of lipid mixing (given as the percentage of maximal
mixing) was evaluated according to the following formula:
100 x ( F t - F0)/(Fd- F0). Here, F0 is the R18 fluorescence of the virus-cell
mixture starting at time zero (immediately following the addition of the
virus to the cells), Ft is the R~8 fluorescence at time t, and Fa is the Ras
fluorescence in the presence of detergent.

Glutaraldehyde treatment of Rls-labelled SIVm~ ~. Ras-labelled virus
was incubated with 0.025 % glutaraldehyde for 30 min at 37 °C. The
glutaraldehyde-treated viral stock was then diluted 38-fold with
M e d i u m A and incubated with cells at 4 °C for 30 min. Subsequently
the temperature of the mixture was raised to 37 °C. The extent of RlSdequenching was determined 30 min later. W h e n glutaraldehyde was
added directly to the virus-cell mixture at the same final concentration,
it had no effect on the Ras-dequenching.
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The temperature was then raised rapidly to the value desired and the
extent of lipid mixing was determined 30 min later.

Inhibition of fusion by recombinant soluble CD4. The virus (1 lag) was
pre-incubated at 37 °C with various concentrations o f C D 4 for 30 min.
The cells (2 x 106) were then added and the extent of lipid mixing within
60 min was determined. The volume of the interaction was 0"3 ml. In
control experiments, the virus was pre-incubated alone at 37 °C and
then added to the cells.
Effect of anti-SIVm, c neutralizing sera and anti-Leu3a antibodies on
the fusion of SIV,,,~ with CD4+ and CD4- cells'. The cells (2 x 106) and
the virus (l pg) were incubated for 60 min at 37 °C in the presence o f
different concentrations of sera. In the case of anti-Leu3a antibodies,
the cells (2 x l0 s) were first incubated with the antibody (25 gg/ml) for
30 min at room temperature and then R18-1abelled virus (1 lag) was
added. The mixture (0.3 ml M e d i u m A) was incubated for 30 min
at 4 °C and then the temperature was raised to 37 °C for 30 min. The
extent of lipid mixing was determined as above.

Cytoplasmic entry of viral core proteins (p27). The a m o u n t o f viral
core proteins introduced into the cytoplasm during the virus-cell fusion
experiments, was determined by quantifying the a m o u n t of trypsinresistant, cell-associated p27. Samples from the virus~cell mixture were
removed following the 30 min incubation at 4 °C and then at the 30, 60
and 180 min time points at 37 °C. Usually, 0.5 gg total viral protein
(10% of which represents p27) were used in order to reliably quantify
the a m o u n t of p27 that became cell-associated or internalized. At each
time point, the a m o u n t of p27 in the supernatants and in the cell pellet
was determined, in order to evaluate the percentage of p27 that became
cell-associated (bound and internalized). The internalized a m o u n t of
p27 was determined subsequently, by subjecting the washed cells to
trypsinization (25 lag of trypsin/10 s cells in 1 ml of PBS for 15 min at
37 °C), to remove any cell-bound but unfused virus. The cells were then
placed on ice and an equal volume of FBS was added. Following
centrifugation at 2 0 0 g for 10 min in 30% FBS, the cell pellet was
washed twice with M e d i u m A. The n u m b e r of cells in each sample was
then determined. The cells were lysed with 0.5% (v/v) Triton X-100
and the a m o u n t of viral core protein introduced into the cytoplasm was
quantified by measuring the a m o u n t of p27 in the cell lysates.
Infection. During the S I V m ~ z e l l fusion experiments, following 1 h
incubation at 37 °C samples containing 0.5 lag total viral protein of R~slabelled SIVm~c and 2 x l0 Gcells were withdrawn. They were diluted 20fold and centrifuged at 4 ° C for 1 0 m i n at 200g. The cells were
washed three times in order to remove the u n b o u n d virus, resuspended
in 4 m l RPMI-1640 medium supplemented with 10% FBS, and
incubated in 12-well tissue culture plates (Lincoln Park). Every 3 or 4
days post-fusion (infection), 2 ml samples from the cell supernatant
were collected and 2 ml of fresh medium was added without further
manipulation of the cells. These samples were used for SIVm~0 core
antigen (p27) determination.

Results

Effect of p H and temperature on S I V ~ - c e l l fusion. To evaluate the
effect of p H on the fusion of SIV with cells, the virus (1 lag) was first
incubated with the cells (2 x 106) at 4 °C for 30 rain at neutral p H in
M e d i u m A (0.1 ml). The pH was then lowered to the desired value by
the addition of appropriate a m o u n t s of acetate (2 M-stock solution
pH 1.5). The temperature of the mixture was then raised to 37 °C for
30 min and the extent of lipid mixing was evaluated as described above.
Cell viability, determined by trypan blue exclusion, was not affected
during this period. The effect of temperature on the fusion potential o f
the virus was determined as follows: R~8-1abelled virus (1 lag) was preincubated with cells (2 x 10~) in 0.3 ml of M e d i u m A for 30 min at 4 °C.

SIVm, c binds to both C D 4 + and C D 4 - m e m b r a n e s

The results shown in Fig. 1 demonstrate that, under the
conditions used, SIV .... 251 could bind at 4 °C both to
C D 4 + and C D 4 - human cell plasma membranes. H o w ever, the number of SIV .... -binding sites on the surface
o f Raji cells appeared to be saturated at lower concentrations of virus compared to the H9 and Sup-T1 cells.
At a low virus-to-cell ratio, more virus was actually
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correlate with the percentage of CD4 + cells present in
each cell line. Lipid mixing was less with Sup-T1 cells
(over 99 % CD4 ÷) than with H9 (about 50 % CD4 +) or
A3.01 cells (over 9 0 % CD4+). Extensive virus-cell
membrane fusion was also observed when SIV .... was
incubated with Raji and K562 cells, which were C D 4 according to fluorescence-activated cell sorting analysis.
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Fig. 1. Binding of SIVm~c to cells. Increasing amounts of Rls-labelled
virus were incubated at 4 °C for 30 rain with 2 x 106 (A) Raji, ([3) H9
and (C)) Sup-T1 cells in 0.1 ml of Medium A. The mixture was then
diluted 20-fold and centrifuged for 10min at 200g at 4°C. The
pelleted cells were resuspended and washed twice with Medium A. The
amount of virus that became cell-associated was evaluated by
measuring the R~ fluorescence of the combined supernatants and of
the cellular pellet. Results represent the average values of three
experiments. The maximum deviation from the mean was within 20 %
of the mean. The numbers in parentheses indicate the calculated
number of virions bound per cell at the highest virus-to-cell ratio.

bound to Raji than to Sup-T1 or H9 cells. However, as
this ratio increased, the Sup-T1 and H9 cells bound more
virus than the Raji cells. The estimated number of virions
bound per cell is indicated for the highest virus-to-cell
ratio used (10 tag SIV/2 x 106 cells/0.1 ml Medium A)
(Fig. 1). The number of virions was calculated assuming
a protein-to-lipid ratio similar to that for HIV-1 and an
average virion size of 130 nm (Aloia et al., 1988).

The viral envelope fuses with both CD4 + and CD4human cell plasma membranes, but not with CD4 ÷ nonhuman cell lines
The incubation of Ras-labelled virus with cells at 4 °C for
as long as 1 h resulted in negligible Ras-dequenching, an
indication that although virus is bound to the cells (Fig.
1 and Table 3), virus-cell fusion does not occur (Fig. 2).
When the temperature was raised to 37 °C, only a
minimal increase in Rxs-dequenching was observed in the
case of the non-human cell lines. However, an increase in
the R18-dequenching was observed as a function of time,
with CD4 + and C D 4 - h u m a n cells (Fig. 2). Following an
initial rapid phase of 30 min, the rate of R~s-dequenching
decreased, but lipid mixing proceeded even after 60 rain
at 37 °C. The extent of lipid intermixing observed did not

It is possible that upon virus-cell incubation, a fraction
of the virus-associated Rls molecules are transferred to
the cell plasma m e m b r a n e by simple exchange in the
absence of m e m b r a n e fusion. It is important, therefore,
to adjust the value for Rls-dequenching monitored
during virus-cell fusion for possible ' p r o b e exchange'.
Several control experiments were performed and the
results are presented in Table 1. When 1 lag Rls-labelled
virus was incubated with 2 x 106 H9 or Raji cells up to
1 h at 4 °C in 0.1 ml of Medium A a minimal dequenching
of the RI, fluorescence was found. Longer incubations
(up to 5 h) resulted in less than 4 % dequenching. The
dequenching of R18 was mediated by the viral proteins,
since a negligible dequenching of the Ra8 fluorescence
was found when R18-1abelled liposomes, of a lipid
composition similar to that of the viral envelope, were
incubated with 2 x l0 G cells for 1 h at 37°C. Glutaraldehyde (0.025 % v / v ) treatment of 1 lag Rls-labelled
virus with 2 x 106 cells in 0"3 ml of Medium A for 30 min
at 37 °C, had a drastic effect on the lipid mixing ability of
our viral preparation. Although the binding to H9 cells
was unaffected by the glutaraldehyde treatment, a 25 %
increase in binding was found in the case of Raji cells.
The Rls-dequenching was completely inhibited in H9 cell
samples, and was reduced by 75 % in the Raji cells. It
was evident that glutaraldehyde treatment did not affect
the ability of Ras to dequench as shown by the
observation that detergent addition could indeed cause
the maximal dequenching expected from a similar
amount of untreated labelled virus. The extent of
inhibition of dequenching by glutaraldehyde in our
experiments was similar to or higher than that reported
for several other enveloped viruses such as Rous sarcoma
virus (Gilbert et al., 1990) and respiratory syncytial virus
(Srinivasakumar et al., 1991).

Effect of sCD4 and anti-Leu3a antibodies on virus-cell
fusion
Soluble CD4 inhibits infection of CD4 + lymphocytes and
monocytes by HIV-1, HIV-2 and SIV in a concentrationdependent fashion (Clapham et al., 1989). We determined
whether sCD4 would block the fusion of the viral

Fusion and infectivity of SIV,,,.~251
T a b l e 1. Rls-exchange control experiments
Type of control

Cell line

Incubation at 4 °C
Liposomes*
Glutaraldehydet

H9 or Raji
H9 or Raji
H9
Raji

100

Fluorescence-dequenching (%)
< 1
<2
< 1 (20)
5 (20)

* The liposomeswere composed ofcholesterol/phosphatidylcholine/
sphingomyelin/phospatidylethanolamine and phosphatidylserine at
the molar ratios reported for HIV clinical isolates (Aloia et al., 1988).
The concentration of the liposomes was 0.48 nmol of lipid, corresponding approximately to 1 gg of total viral protein.
t Values in parentheses indicate the percentage of R~8-dequenching
measured when the virus was not treated with glutaraldehyde.

5o

"7,

0

[]
0

T a b l e 2. Effect of sCD4 and anti-Leu3a on virus-cell

~
20

membrane lipid mixing
Inhibition of lipid mixing (%)*
Cell line
H9

Raji

Concentration
of agent (gg/ml)

sCD4

x-chain

Anti-Leu3a

0.1

19+ 15

1

36 ± 6

5
l0
25
0"1

68+14
ND
ND
13"5--+6
35 _+12
58 ± 25
68+8
ND

0
ND
5+_2
17 _+10
ND
0
ND
ND
27-+10
ND

NDt
ND
ND
ND
30_+6 (35)
ND
ND
ND
ND
--8-+3 (< 1)

1

5
10
25
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* Mean values and the standard deviation from the mean of three
experiments are given. Negative values indicate an enhancement of
membrane lipid mixing. Values in parentheses indicate the percentage
inhibition of virus-cell binding.
"~ ND, Not determined.

80

Fig. 2. Lipid mixing of the viral envelope with various CD4+ and CD4
cell plasma membranes. One gg of Rls-labelled SIV..... was added to
2 x 10n (11) A3.01, (A) Raji, (O) Sup-T1, (A) K562, (D) H9, ([]) EL4 and (A) Mv- 1-1ucells in 0.1 ml of Medium A. At the starting time the
mixture was placed at 4 °C for 30 min and then the temperature was
raised to 37 °C. Samples were withdrawn from the mixture and diluted
20-fold with the same medium. In the case of the adherent cells (Mvl-lu), the cellswere collected from the plate at the indicated time points,
as described in Methods. The Rls fluorescenceof each sample was then
measured in the presence and absence of 1% (v/v) detergent. The
extent of virus-cell fusion was evaluated as described in Methods.
Points represent the mean value of three to five independent
experiments, each done in triplicate. The maximum deviation from the
mean was within 10% of the mean.

T a b l e 3. Effect of neutralizing anti-SIVm,c251 sera on

viru~ceIl membrane mixing
Cellline

envelope with the cell p l a s m a m e m b r a n e s (Table 2). The
virus (1 lag) was p r e - i n c u b a t e d with sCD4 for 30 m i n at
37 °C, a n d the cells (2 x 106) were a d d e d to the mixture,
while keeping the blocking agent c o n c e n t r a t i o n c o n s t a n t .
This i n c u b a t i o n was p e r f o r m e d in 0"3 ml o f M e d i u m A
a n d the extent of virus-cell lipid m i x i n g was evaluated
1 h later. As indicated in T a b l e 2, sCD4 inhibited Rlsd e q u e n c h i n g , a n d the i n h i b i t i o n , d e t e r m i n e d by comp a r i n g the extent o f lipid mixing in the presence or
absence of these agents, was c o n c e n t r a t i o n - d e p e n d e n t .
P r e - i n c u b a t i o n with a non-specific p r o t e i n (goat antih u m a n ~c light-chain) resulted in i n h i b i t i o n only at high,
b u t n o t low, c o n c e n t r a t i o n s , i n d i c a t i n g that s C D 4
i n h i b i t i o n is specific. W e did n o t investigate whether
sCD4 inhibited cell infection in a similar fashion. W h e n
the virus was a d d e d to H9 cells that had been prei n c u b a t e d with a n t i - L e u 3 a antibodies for 30 m i n at
22 °C, a 30 % i n h i b i t i o n o f R18-dequenching, a n d a 35 %
i n h i b i t i o n o f b i n d i n g was f o u n d . I n contrast, a n t i - L e u 3 a
t r e a t m e n t of Raji cells h a d n o effect o n the extent o f

40
60
Time (min)

H9
R~i

Serumdilution

Inhibition of R18-dequenching (%)

1:500
1:1000
1:500
1:1000

95 ± 5
23±10
95
50±11

virus-cell b i n d i n g a n d p r o d u c e d a slight e n h a n c e m e n t o f
Rls-dequenching.

Inhibition of virus-cell membrane fusion by antiSIVm,~251 sera
W h e n the virus (1 lag) was i n c u b a t e d for 1 h with 2 × 106
H9 or Raji cells in the presence of different c o n c e n t r a tions o f anti-SIVm~c251 sera (in 0"3 ml of M e d i u m A), a n
i n h i b i t i o n of m e m b r a n e fusion, as m e a s u r e d by the
extent o f virus~zell lipid mixing, was f o u n d (Table 3)
b o t h in the case o f the C D 4 + a n d C D 4 cells. The
percentage o f i n h i b i t i o n was d e p e n d e n t o n the conc e n t r a t i o n of the sera.

1048

L. Stamatatos and N. Diizgiine¢
constant over the cell concentration range studied, if the
probe were easily exchangeable.
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SIVmac-cell fusion is pH-independent
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Fig. 3. Effect of cell concentration on the extent of fusion of SIVm~c
with (@) Sup-Tt, (D) H9 and (A) Raji ceils. Rls-labelled SIVm~e
(0.1 gg) was incubated for 30 rain at 4 °C with an increasingnumber of
cells in 0.1 ml of Medium A. The temperaturewas then raised to 37 °C.
The extent of fusion was evaluated 1 h later, by measuring the Ras
fluorescenceof each sample in the presence and absence of 1% (v/v)
detergent. Points represent the mean value of three independent
experiments. The maximal deviation from the mean was 20 % of the
mean.

Cell concentration affects the extent of fusion
Rls-labelled SIVm~e251 (0"1 lag) was incubated with
increasing cell concentrations at 4 °C for 30 min and the
temperature of the mixture (0"1 ml total volume) was
raised to 37 °C for 1 h. The extent of lipid mixing was
then determined for each cell concentration. At low cell
concentrations, the Rls-dequenching exhibited a sharp
increase as the number of cells increased (Fig. 3). As
predicted from mass action kinetics, this result indicates
that the number of virions that fuse with the cells
increases as the target cell concentration increases. The
slightly lower extent of fusion observed with 2 x 10" cells
and 0.1 lag of virus, compared to that obtained with 1 lag
of virus (Fig. 2), is most likely due also to mass action
kinetics. At high cell concentrations ( > 2 x 10" cells/ml),
the extent of R18-dequenching did not increase with
increasing cell number as much as at lower cell
concentrations, suggesting that a limited number of
fusion sites per cell is available on the cell surface. This
observation also suggests that the increase of Rls
fluorescence is not an artefact due to simple exchange of
the fluorescent probe into the cell membranes in the
absence of lipid mixing. Since the total cell surface area
is much larger than the viral surface and a large excess of
target membranes was used during our experiments, we
would have expected that the slope of the curve of R18dequenching plotted against cell concentration would be

Certain enveloped viruses such as influenza and vesicular
stomatitis viruses infect cells by taking advantage of the
endocytic machinery of the cells (Matlin et al., 1981;
Marsh & Helenius, 1989). The acidification of the
endosomal fluid causes conformation changes in the viral
fusion proteins, which then mediate fusion of the viral
envelope with the endosomal membranes (Hoekstra,
1990; Stegmann et al., 1989). However, other enveloped
viruses, such as Sendai virus and HIV-1, can fuse with
their target membranes with a pH-independent mechanism (Lima et al., 1991; Sinangil et al., 1988). It is
generally accepted that, like HIV (Maddon et al., 1988),
SIV does not require endocytosis for infection. We
examined the effect of pH on the membrane fusion
ability of SIV ..... 251 by following the extent of Rlsdequenching occurring between the viral envelope and
the cell plasma membrane (Fig. 4). Our results indicate
that the fusion measured in this way was neither
promoted nor inhibited by acidification of the medium.

The fusion of the viral envelope with the cell plasma
membrane is temperature-dependent
Several studies have shown that enveloped viruses can
fuse with target membranes in a temperature-dependent
fashion (Gilbert et al., 1990; Hoekstra et al., 1989;
Srinivasakumar et al., 1991; Dfizgfine~ et al., 1992). It
was therefore of interest to examine the temperature
dependence of SIV--cell fusion. As can be seen in Fig. 5,
at temperatures below 15 °C no R18-dequenching was
found. An increase of Rls fluorescence was observed only
when the temperature was raised above 15 °C. The
temperature dependence of membrane fusion was similar
for both CD4 + and CD4 cells.

Infection of cells' by SIVmac251 as determined by virus
production in the cell culture medium
Our results on lipid mixing between the virus and human
cells were unexpected. The extent of lipid mixing was
independent of the percentage of CD4 + cells present in
the incubation mixture (Fig. 2, 3, 4 and 5). Although
similar observations were reported by others examining
the fusion between cells expressing gpl20/gp41 (HIV-1)
and cells expressing different amounts of CD4 (Dimitrov
et al., 1991), the fact that extensive lipid mixing was
observed with both CD4 + and CD4- cells was intriguing.
Therefore, we investigated whether SIV .... -cell fusion

Fusion and infectivity of SIVm,~251
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Fig. 4. Effect of pH on the fusion of SIV.... with (~) Raji, (O) SupT1 and ([-7) H9 cells. One lag of Ra8-1abelled SIV..... was added to
2 × 106 cells in 0.1 ml of Medium A for 30 min at 4 °C. The pH of the
medium was then lowered to the desired value upon addition of a
predetermined amount of concentrated acetate solution (2 M, pH 1'5).
The temperature of the mixture was then raised to 37 °C for 30 min.
The extent of virus-cell fusion was evaluated as described in Methods.
Results represent average values of three independent experiments
(performed within a period of 3 months after virus purification). The
maximum deviation from the mean was within 15 % of the mean.
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Time after SIV--cellfusion (days)
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Fig. 6. Infection of cells by SIVmao251 as determined by virus
production in the cell culture medium. Following virus-cell fusion
(30 min at 4 °C and 1 h at 37 °C) the ([7) H9, (O) Sup-T1 and (11)
K562/A3.01/Raji cells were washed by centrifugation three times,
resuspended in 4 ml of culture medium and cultured up to 28 days.
Every 3 to 4 days post-fusion (i.e. post-infection) 2 ml of medium was
replaced and the presence of the viral core protein p27 was evaluated,
as described in Methods. The results are the mean and standard
deviation of three independent experiments.

the different h u m a n cell lines was allowed to proceed for
1 h. The cells were t h e n washed three times to remove the
u n b o u n d virus a n d resuspended in n o r m a l m e d i u m . The
presence of p27 in the cell culture m e d i u m was m o n i t o r e d
every 3 to 4 days, u p to 28 days post-fusion. P r o d u c t i v e
infection was m o n i t o r e d only in the case o f Sup-T1 a n d
H9 cells (Fig. 6). The third C D 4 + cell line ( A 3 . 0 1 ) a n d
the two C D 4 - cell lines were n o t infected productively,
according to this assay. Large syncytia could be observed
in the H9 cultures 16 days post-infection. Syncytia were
n o t observed in the case of Sup-T1 cells, b u t very large
cell aggregates b e g a n to form 15 days post-infection. I n
the cases of A 3 . 0 1 , Raji a n d K562 cells n o such changes
were observed.

20

.9

~r 10

00

~"

'

llO

20
Temperature (°C)

30

40

Fig. 5. Effect of temperature on the fusion of SIVm~0with Raji (A) and
H9 ([7) cells. One gg of R18-1abelledSIV.... was added to 2 x 106 cells
in 0-3 ml of Medium A for 30 min at 4 °C and the temperature of the
mixture was raised to the value indicated. The extent of R18dequenching was evaluated 30 min later.

resulted in productive infection, by e v a l u a t i n g the
p r o d u c t i o n o f virus in the cell culture m e d i u m several
days p o s t - f u s i o n (Fig. 6). F u s i o n between SIVmae251 a n d

Virus association and internalization of the nucleocapsid
during virus-cell fusion
The fact that we could observe fusion (lipid mixing) o f
the viral envelope with the p l a s m a m e m b r a n e s of A 3 . 0 1 ,
Raji a n d K562 cells, a l t h o u g h these cells r e m a i n e d
uninfected, p r o m p t e d us to investigate in m o r e detail the
initial interactions between the cells a n d the virus. T h e
Ra8 analysis reveals solely the rate a n d extent of lipid
i n t e r m i x i n g occurring d u r i n g virus-cell m e m b r a n e fusion. Therefore, it is possible that in some cases, lipid
mixing occurs only (or primarily) between the outer lipid
m o n o l a y e r s o f the viral a n d cell m e m b r a n e s w i t h o u t
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Table 4. Virus-cell association and entry o f p27 into
CD4 + and CD4- cells
Percentage of
cell-associated
p27

Percentage of
total p27 added
that becomes
internalized

Conditions

Cell line

30 min at 4 °C
30 min at 37 °C
60 min at 37 °C

H9

29.4 (4)*
17.5 (4.3)
11 (5)

0
1 (0.1)
2 (0.3)

30 rain at 4 °C
30 min at 37 °C
60 min at 37 °C

Sup-T1

32 (4.5)
19 (5)
13 (6)

0
2 (0.5)
7 (1)

30 min at 4 °C
30rain at 37 °C
60 rain at 37 °C

Raji

27.5 (5)
16.5 (6)
17 (6)

0
0.1 (0.1)
0.2 (0.1)

60 min at 37 °C

K562

12.3

0.3 (0.1)

30 min at 4 °C
60 min at 37 °C

A3.01
A3.01

17 (5)
21 (9)

0
0.4 (0.2)

* The values represent the mean and standard deviation (in
parentheses) from the mean of three to five independent experiments.

entry of the nucleocapsid into the cytoplasm, a type of
fusion called 'semi-fusion' (Dfizg/Jne~, 1985). This
possibility led us to examine whether, concurrently with
lipid intermixing, viral core proteins are introduced into
the cytoplasm.
Two-million cells were incubated with R18-labelled
virus (15 ng of p27) for 30 min at 4 °C and then the
temperature was raised to 37 °C to examine p27
internalization (Table 4). At different times the cells were
washed to remove the unbound virus and the amount of
cell-associated p27 was determined. The amount of p27
internalized, out of the total added, was evaluated
following trypsinization of the washed cells, as described
in Methods. The results of these experiments are
presented in Table 4. Incubation of virus with cells at
4 °C resulted in association of the virus with the cell
surface measured by the amount of p27 that became cellassociated. Following trypsinization of the cell surface,
we could not detect any p27 (or RlS) associated with the
cell pellets, an indication that all the virus associated with
the cells remained on the cell surface at 4 °C and was not
internalized. This result correlates well with the results
obtained with the R18 assay, which showed no lipid
mixing occurring between the virus and the cells at this
temperature (Fig. 2 and 5). Upon raising the temperature
to 37 °C, the amount of cell-associated p27 decreased,
because at high temperatures some dissociation of the
virus from its binding sites occurs (Hoekstra & Klappe,
1986; Nir et al., 1986). At the same time we could
observe an increase in the amount of p27 that was
internalized (trypsin-resistant), in the case of H9 and
Sup-T1 cells. The amounts of p27 internalized increased
with the incubation time at 37 °C. In the case of A3.01,
Raji and K562 cells, however, a very low proportion of

the total p27 amount that was added became internalized. This indicates that the virus is unable to enter
these cells efficiently by directly fusing either with the
plasma membranes or with endosomes following endocytosis.

Discussion
Enveloped viruses introduce their genetic material into
host cells by binding to and subsequently fusing with
cellular membranes (Hoekstra, 1990; Marsh & Helenius,
1989). Virus-cell fusion is a complex event involving
several viral and cellular molecules (Marsh & Helenius,
1989; Stegmann et al., 1989; Hoekstra, 1990). The
binding of HIV and SIV to CD4 + cells is thought to be
mediated by gpl20-CD4 interactions (Dalgleish et al.,
1984; Kannagi et al., 1985; Klatzmann et al., 1984;
McDougal et al., 1985). Several CD4- cells, however, can
be infected by HIV-1 (Dalgleish et al., 1984; Kannagi et
al., 1985; Klatzmann et al., 1984; McDougal et al.,
1985), and alternative pathways of HIV-1 entry not
involving the CD4 molecule have been proposed (Tateno
et at., 1989; Harouse et al., 1991 a, b). Although the CD4
molecule is an important factor in SIV infection, several
CD4 + cells are not capable of being infected in vitro by
SIVm~c251 and SIV~n~ (Agy et al., 1991; Hoxie et al.,
1988; Koenig et at., 1989). This implies that in addition
to CD4, the expression of one or more, as yet
unidentified, cellular surface molecules could be required
for SIV infection (Hoxie et al., 1988; Koenig et al., 1989).
These molecules could be involved in the binding,
membrane fusion or the immediately subsequent events
that lead to entry of the viral nucleocapsid into the
cytoplasm. To elucidate the extent of the interaction of
SIV.... 251 with non-infectible cells, we examined viruscell binding and fusion, intracellular entry of viral core
proteins and productive infection of three human and
two non-human CD4 + and two human CD4- cell lines,
which have widely differing capacities for infection by
S1V.... 251.
The amount of SIV.... bound to the cell surface at
4 °C was determined by quantifying the amount of either
Rls or p27 associated with the cells and remaining in the
cell supernatant. Both assays gave similar results (data
not shown). The fact that, at any SIV ...../cell ratio, more
virus is bound on the surface of Sup-T1 cells (100%
CD4 + by flow cytometry) than on the surface of H9 cells
(55 to 65 % CD4 +) (Fig. 1) suggests the involvement of
CD4 in the binding of SIVm~0 to the surface of these
CD4 + cells. The virus also bound to the surface of CD4
cells (Raji and K562). It appears that the binding sites on
the CD4- cells (Raji) are saturated at low concentrations
of virus, and that saturation of the binding site(s) on
CD4 + cells requires higher amounts of virus. It is
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possible, although unlikely, that SIVmae binds to a small
number of CD4 + cells present in the Raji and K562
(Table 3) population, this being undetectable by flow
cytometric analysis, or that the virus uses alternative
binding sites on the surface of these CD4 cells.
Additionally, SIV .... may bind to CD4- cell surfaces via
non-specific interactions, under the binding conditions
used. It has been demonstrated previously that HIV-1 sr3a
can also associate strongly with the surface of CD4
cells, including Raji cells (Tang & Levy, 1991). AntiLeu3a antibodies partially inhibited the binding and
fusion of the viral envelope with the plasma membrane
of H9 cells (Table 2) but had no effect on the binding of
SIVm~o to Raji cells and slightly promoted the extent of
R18-dequenching in this latter case. Under identical
conditions, 70 % inhibition was found in the case of
HIV-1 and H9 cells (L. Stamatatos et al., unpublished).
It is possible that SIVm~-cell binding occurs through
domains on the cell surface that are composed of cellular
membrane lipids, as was reported for HIV-I--cell binding
(Harouse et al., 1991a, b; Yahi et al., 1992). Binding
achieved through such lipid domains could result in lipid
mixing, once the temperature is increased to 37 °C, and
be responsible for the lipid mixing found with the CD4cells.
The extent of lipid mixing, as measured by the Rlsdequenching assay, did not correlate with the percentage
of CD4 + cells present in the cell culture (Fig. 2). The
membrane of SIVmae could mix with the membranes of
both CD4 ÷ and CD4- human cells. It was demonstrated
previously, using the same fluorescence technique, that
HIV-1NXT E could fuse with the plasma membrane of
human-derived CD4 + T cell lines and with CD4- brainderived cells, but not with a gibbon CD4 T lymphocyte
line (Sinangil et al., 1988; Volsky, 1990). Our results with
the EL-4 and Mv-l-lu cells indicate that no appreciable
membrane lipid mixing occurred with the membranes of
these non-human cells. Thus, membrane lipid mixing
was essentially confined to the human cell lines tested in
this study. This observation suggests that certain, as yet
undetermined, components of human cell membranes
are likely to be involved in sustaining the fusion of the
SlVmac envelope.
The extent of SIVma~-cell lipid mixing was independent
of the pH of the medium (Fig. 4). In this respect the pH
profiles of SIVm~~ and HIV-l-cell membrane fusion are
similar (Sinangil et al., 1988). Protonation of the viral
envelope proteins does not seem to be required for fusion
of SIVmae with cell membranes, while the fusion of
SIVm~~ with liposomes containing primarily negatively
charged lipids was shown to be enhanced at low pH
(Larsen et al., 1990). Our results, however, demonstrate
that SIV.... does not lose its overall fusion ability at low
pH and it is possible that virions can introduce their
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nucleocapsid into the cytoplasm following endocytosis
or phagocytosis.
The temperature dependence of fusion was shown
previously for Sendai virus-erythrocyte ghost fusion
(Hoekstra et al., 1989), and for the fusion of respiratory
syncytial virus (Srinivasakumar et al., 1991), Rous
sarcoma virus (Gilbert et al., 1990) and influenza virus
(Dfizgfine~ et al., 1992) with cultured cells. Here the
fusion of SIV .... with both CD4 + and CD4 cells was
shown to be temperature-dependent (Fig. 5). Below
15 °C no R~8-dequenching was found. The extent of
membrane fusion does not have a linear relationship
with increasing temperature. It appears that the extent of
fusion increases more rapidly at temperatures above
25 °C.
Soluble CD4 and neutralizing anti-SIV.... sera inhibited SIVmae--cell lipid mixing in a concentrationdependent manner (Tables 2 and 3). The fact that lipid
mixing was inhibited with both CD4 + and CD4 cells
suggests that gpl20 is involved in the interaction of
SIVm~ e with both cell types. It is known that pretreatment
of several laboratory strains of HIV-1 with sCD4 results
in the removal of gpl20 from the viral surface (Moore et
al., 1990). This could also occur with SIVm~e251 and
impair the ability of the virus to bind to the cell surface.
Alternatively, the loss of gpl20 molecules from the viral
surface exposes underlying gp40 molecules that in the
absence of target membranes might result in the
inactivation of the viral fusion capacity. A similar type of
inactivation was reported for influenza virus. Although
acidification of the medium is required for activation of
the fusion potential of influenza virus, exposure of the Nterminal fusion peptide of haemagglutinin in the absence
of target membranes (by pre-incubation of the virus at
low pH), results in virus inactivation (Stegmann et al.,
1987; Diizgfine~ et al., 1992).
As expected from the results of the lipid mixing assay
(Fig. 2), incubation of SIV .... with cells at 4 °C did not
result in p27 internalization (Table 4). At 37 °C, however,
fusion of the viral envelope with the plasma membranes
of human cells resulted in efficient entry of p27 into
certain CD4 + cells (H9 and Sup-T1) but not into others
(A3.01). No significant entry into CD4 cells was
observed. In the cases of H9 and Sup-Tl cells, the
percentage of cell-associated p27 (cell-bound and internalized) decreased with time, due to dissociation of a
fraction of the cell-bound virus at 37 °C, as reported
previously for Sendai virus (Hoekstra & Klappe, 1986).
In the case of H9 and Sup-T1 cells, the amount of p27
internalized (determined following cell surface trypsinization) increased with increasing time of incubation at
37 °C, due to fusion of virions with the cells and
cytoplasmic entry of the viral nucleocapsid. The fact that
extensive lipid mixing takes place between the virus and
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all the human cells tested, although p27 enters primarily
into the cytoplasm of only two CD4 + cells (Sup-T 1 and
H9), suggests that CD4 is necessary, but not sufficient,
for viral core entry. Additional cell surface molecules may
therefore be required for efficient cytoplasmic entry of
the nucleocapsid. In the case of A3.01 and the CD4human cells, these molecules seem to be absent (or
inactive) and virus-cell interactions probably result in
the formation of small areas of contact through which
mostly lipid molecules can intermix. Alternatively, it is
possible that in the case of H9 and Sup-T1 cells, but not
in the other cases, SIV .... was internalized by endocytosis, and this would imply that endocytosis was
required for infection. Another explanation for the nonentry of the nucleocapsid could be the presence of
molecules on the surface of the CD4- and the A3.01 cells
that inhibit viral core entry.
In the case of H9 and Sup-T1 cells, lipid mixing
proceeds at a much faster rate than the rate at which the
nucleocapsid is internalized (Fig. 2 and Table 3). Similar
observations were reported recently with influenza
virus-cell fusion. The rate of lipid mixing was much
faster than the rate of nucleocapsid entry when the
temperature of the reaction was below 37 °C (Lowy et
al., 1992). In order for the viral nucleocapsid to enter the
cytoplasm several events, such as re-organization of cell
surface proteins and of the cytoskeleton, may have to
take place and these events may require more time than
does lipid mixing. The observed quantitative differences
between the p27 entry and the Rls-dequenching assays
could be due to additional factors. A small proportion of
dead cells (between 0 and 10% depending on the
experiment) which were not separated from live cells
during our experiments could have contributed to Rlsdequenching. In addition, some virions could begin to
fuse with cell membranes but owing to structural
abnormalities in their envelope the fusion process may be
incomplete, resulting in lipid mixing but not p27 entry.
Electron microscopic observations of HIV-1 fusing with
H9 cells have indeed revealed structures which have been
interpreted as the fusion of the outer leaflets of the viral
and cellular membranes (Grewe et aI., 1990).
Although some of the Rls-dequenching may be due to
transfer (exchange) of the fluorescent probe from the
viral envelope to the cell plasma membranes, our control
experiments (Table 1) indicate that only a very small
fraction (if any) of the R~s-dequenching monitored was
attributable to 'probe-exchange'. Rls-dequenching was
observed only when the temperature was raised above
15 °C, although the virus could associate with the cell
surface below that temperature. Glutaraldehyde treatment of Rts-labelled virus resulted in a drastic reduction
of the R~,-dequenching, while not inhibiting the binding
capacity of the virus for H9 cells. These observations

strongly support the interpretation that the Rlsdequenching occurring is due to membrane lipid mixing.
Similar inhibition of virus-cell membrane fusion upon
glutaraldehyde treatment of the virus was previously
reported for Rous sarcoma virus (75 %; Gilbert et al.,
1990) and for respiratory syncyfial virus (25 %; Srinivasakumar et al., 1991). No Rls-dequenching was observed
when Rls-labelled liposomes with a lipid composition
similar to that of the viral envelope were incubated with
the cells. The observation that lipid mixing with two
non-human cells expressing the CD4 molecule was
minimal (Fig. 2) provides further evidence that the
fluorophore does not transfer at a molecular level to just
any target membrane. In addition, although p27 entry
was very inefficient in the case of the human CD4 cells,
the fact that some p27 was present in the cytoplasm of
these cells (Table 4) is evidence for the occurrence of
membrane lipid mixing of the viral envelope with the
surface of these cells. Others (Potash et al., 1992) have
reported that HIV-l~cell membrane fusion does not
necessarily result in productive infection of alveolar
macrophages. It is possible, therefore, that although
virus-cell fusion takes place, entry of the viral nucleocapsid is very limited and does not result in productive
infection.
Our infection studies (Fig. 6) confirm the previously
reported observations on the different potential for
infection by SIVm~¢251 of H9 and A3.01 cells (Hoxie et
al., 1988; Koenig et al., 1989). Our finding that Sup-T1
cells are infected by SIV.... 251, in contrast to that
reported by Koenig et al., (1989) is probably due to the
use of a more sensitive assay for virus production and to
a prolonged (up to 28 days) examination of the cell
supernatant for the presence of virus. Our Sup-T1
infection results are in general agreement with those
reported by Hoxie et al. (1988). The p27 internalization
(Table 4) and infection experiments (Fig. 6) demonstrate
a correlation between the quantities of viral core proteins
(and probably RNA) internalized during fusion and the
level of infection (p27 production in the cell culture
medium). The faster rate and the higher quantities of p27
internalized in the case of Sup-T1, compared to values
for H9 cells, resulted not only in earlier signs of
productive infection but also in higher levels of infection
(Fig. 6). In the case of the A3.01 and the CD4 cells, the
entry of the nucleocapsid is very inefficient and does not
result in productive infection. It may be possible,
however, t o ' rescue' virus present in very small quantities
in these cells, by co-cultivation with H9 or Sup-T1 cells.
In addition to the inefficient entry of SIV.... into certain
CD4 + and CD4 cells, cytoplasmic factors may determine
the fate of the initially internalized virion nucleocapsid,
by either allowing or inhibiting viral replication and
productive infection.

Fusion and infectivity o f SIVmac251

O u r results also s u p p o r t t h e h y p o t h e s i s t h a t o t h e r
m o l e c u l e s in a d d i t i o n to C D 4 are r e q u i r e d f o r efficient
e n t r y o f SIVm~c251 i n t o C D 4 ÷ cell lines. W e b e l i e v e t h a t
t h e s e m o l e c u l e s p l a y a r o l e in steps f o l l o w i n g v i r u s
b i n d i n g , p r o b a b l y d u r i n g t h e f o r m a t i o n o f p o r e s t h a t the
n u c l e o c a p s i d p a s s e s t h r o u g h as it e n t e r s t h e c y t o p l a s m . I t
is i m p o r t a n t to i d e n t i f y t h e s e m o l e c u l e s a n d e l u c i d a t e t h e
m e c h a n i s m b y w h i c h t h e y p a r t i c i p a t e in v i r u s e n t r y , in
o r d e r to u n d e r s t a n d b e t t e r t h e m e c h a n i s m s o f r e t r o v i r u s cell i n t e r a c t i o n s .
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